(Q45128964)

9 December 2017

1 reference

title

Liver transplantation in patients with HIV infection: a reality in 2004 (English)

1 reference

9 December 2017

liver transplantation

1 reference

7

1 reference

9 December 2017

José M Miró

1

1 reference

9 December 2017

Miguel Montejo

2

1 reference

9 December 2017

Gabriel Rufí

3

1 reference

9 December 2017

Ramón Bárcena

4

1 reference

9 December 2017

Víctor Vargas

5

1 reference

9 December 2017

Antonio Rimola

6

1 reference

9 December 2017

Andrés Valdivieso

8

1 reference

9 December 2017

Jordi Fabregat

9

1 reference

9 December 2017

Eduardo de Vicente

10

1 reference

9 December 2017

Carles Margarit

11

1 reference

9 December 2017

Asunción Moreno

12

1 reference

9 December 2017

Pilar Miralles

13

1 reference

9 December 2017

Koldo Aguirrebengoa

14

1 reference

9 December 2017

Francesc Xavier Xiol

15

1 reference

9 December 2017

Jesús Fortún

16

1 reference

9 December 2017

Albert Pahissa

17

1 reference

9 December 2017

Montse Laguno

18

1 reference

9 December 2017

Magdalena Salcedo

19

1 reference

9 December 2017

José Miguel Cisneros

20

1 reference

9 December 2017

Carmen Quereda

21

1 reference

9 December 2017

Montse Tuset

22

1 reference

9 December 2017

Juan José Castón

23

1 reference

9 December 2017

Julián Torre-Cisneros

24

1 reference

9 December 2017

Grupo de Trabajo del Transplante Hepático en pacientes infectados por el VIH en España (GTTHVIH)

25

1 reference

9 December 2017

language of work or name

Spanish

0 references

publication date

1 November 2004

1 reference

Infectious Diseases and Clinical Microbiology

9 December 2017

1 reference

9 December 2017

22

1 reference

9 December 2017

9

1 reference

9 December 2017

529-538

1 reference

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

9 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Hepatitis C in the HIV (human immunodeficiency virus) Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): the effect of coinfection on survival

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Hepatitis C is more severe in drug users with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

[Causes of mortality among patients infected with the human immunodeficiency virus in the era of highly active antiretroviral therapy]

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Pegylated IFN-alpha2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Pegylated interferon alpha2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Should all human immunodeficiency virus-infected patients with end-stage renal disease be excluded from transplantation? The views of U.S. transplant centers

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Solid-organ transplantation in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Liver transplantation in adults coinfected with HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Transplantation in the HIV+ patient

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Guidelines for the referral and management of patients eligible for solid organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Review of solid-organ transplantation in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Infection with human immunodeficiency virus in the Pittsburgh transplant population. A study of 583 donors and 1043 recipients, 1981-1986

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Transplantation in HIV+ patients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

The effect of cyclosporine on the progression of human immunodeficiency virus type 1 infection transmitted by transplantation--data on four cases and review of the literature.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

An observational study of 11 French liver transplant recipients infected with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Outcome of orthotopic liver transplantation in patients with haemophilia

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Liver transplantation for an HIV-positive patient in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

[Orthotopic liver transplantation in a 33-year-old patient with fulminant hepatitis B and HIV infection]

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Survival of Human Immunodeficiency Virus–Infected Liver Transplant Recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Responding to organ failure in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Liver transplantation in a patient infected by human immunodefficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Liver transplantation in a patient coinfected with human immunodeficiency virus and hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Distribution of lymphocyte subtypes in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Transplantation for alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Survival and Risk of Recidivism in Methadone-Dependent Patients Undergoing Liver Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Key clinical, ethical, and policy issues in the evaluation of the safety and effectiveness of solid organ transplantation in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Spanish GESIDA/Nacional AIDS Plan Recommendations for antiretroviral therapy in HIV-infected Adults (October 2004)

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Pharmacokinetic interaction between saquinavir and cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Interactions between tacrolimus and antimicrobial agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Nelfinavir, a protease inhibitor, increases sirolimus levels in a liver transplantation patient: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Probable interaction between efavirenz and cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

The addition of mycophenolate mofetil to antiretroviral therapy including abacavir is associated with depletion of intracellular deoxyguanosine triphosphate and a decrease in plasma HIV-1 RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

A pilot study of the use of mycophenolate mofetil as a component of therapy for multidrug-resistant HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

[Infectious disease assessment in solid organ transplant candidates]

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Hepatitis C virus recurrence after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Recurrent hepatitis C after liver transplantation: clinical and therapeutical issues

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Fibrosing cholestatic hepatitis after liver transplantation in a patient with hepatitis C and HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Ribavirin antagonizes the effect of azidothymidine on HIV replication

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Mitochondrial toxic effects and ribavirin

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Weight loss in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Liver transplantation in European patients with the hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

Review: hepatitis B and liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973155-9

7 January 2021

10.1016/S0213-005X(04)73155-9

Identifiers

DOI

1 reference

9 December 2017

1 reference